Skip to main content
Premium Trial:

Request an Annual Quote

Cellomics and BD Recently Awarded US Patents Related to Cellular Assays

Premium

Cellomics has been awarded US Patent No. 6,917,884, "Automated assay for identification of individual cells during kinetic assays."

The inventors listed on the patent are Paul Sammak, Gustavo Rosania, Richard Rubin, Michel Nederlof, Oleg Lapets, Randall Shopoff, and Murugan Kannan.

According to its abstract, the patent protects methods and software for tracking individual cells during a kinetic cell screening assay.


Becton Dickinson has been awarded US Patent No. 6,916,608, "Composition for providing long-term stability to cells for diagnostic testing."

Inventors listed on the patent are Dolores Berger, Daretta Yursis, William Nussbaumer, and Anne Brown.

According to its abstract, the patent protects a method and composition for stabilizing clinical specimens (i.e. cells in biological samples) for transport and subsequent testing for diagnosis. The composition is specifically capable of maintaining nucleic acid in the cells intact for hybridization with oligonucleotide capture and detector probes.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.